PAR 7.50% 21.5¢ paradigm biopharmaceuticals limited..

The Clearly Congruent Canine Compedium, page-20

  1. 4,352 Posts.
    lightbulb Created with Sketch. 6892
    I think you are quite right Ox, they at the moment are fully focused on the two indications....they wouldn't consider a listing for a while yet...
    Too much expense for too little pay back at this early stage.

    Understood exposure would be nice, but not this way...later on....when we are some multiples of where we are at now...
    In my view they are better off ticking more milestones, having the valuable discussions with the authorities , getting on with the trials as quick as possible and then signing up regionals....that will fire us up no end...we will go from strength to raw strength after that.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.